MedPath

Azapropazone

Generic Name
Azapropazone
Drug Type
Small Molecule
Chemical Formula
C16H18N4O2
CAS Number
13539-59-8
Unique Ingredient Identifier
K2VOT966ZI

Overview

No overview information available.

Background

No background information available.

Indication

用于急性痛风性关节炎的治疗,以及血尿酸过多或复发性痛风性关节炎患者(须给予降尿酸药物的治疗),也可用于类风湿关节炎、骨关节炎、强直性脊柱炎。

Associated Conditions

  • Gout Flares
  • Muscle Inflammation
  • Neuralgia, Sciatic
  • Pain caused by Orthopedic Surgeries
  • Pain, Inflammatory caused by Orthopedic Surgeries
  • Rheumatoid Arthritis
  • Localized soft tissue rheumatism

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath